UBS Group AG - MEDOVEX CORP ownership

MEDOVEX CORP's ticker is MDVX and the CUSIP is 58504H101. A total of 8 filers reported holding MEDOVEX CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MEDOVEX CORP
ValueSharesWeighting
Q2 2017$6,000
+20.0%
6,823
+95.7%
0.00%
Q4 2016$5,0000.0%3,486
+12.3%
0.00%
Q3 2016$5,000
+66.7%
3,104
+34.8%
0.00%
Q2 2016$3,0000.0%2,302
-16.2%
0.00%
Q1 2016$3,000
-94.1%
2,748
-94.1%
0.00%
Q4 2015$51,000
+1600.0%
46,434
+3693.6%
0.00%
Q3 2015$3,000
+200.0%
1,224
+427.6%
0.00%
Q2 2015$1,000
-92.9%
232
-93.5%
0.00%
Q1 2015$14,0003,5470.00%
Other shareholders
MEDOVEX CORP shareholders Q1 2016
NameSharesValueWeighting ↓
MERIDIAN INVESTMENT COUNSEL INC. 50,000$66,0000.04%
Coastal Bridge Advisors, LLC 25,000$33,0000.01%
M Holdings Securities, Inc. 10,000$13,0000.01%
Acrospire Investment Management LLC 4,683$6,0000.00%
Citadel Advisors 15,477$21,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,288$20,0000.00%
BlackRock Fund Advisors 4,099$5,0000.00%
VANGUARD GROUP INC 38,398$51,0000.00%
UBS Group AG 3,486$5,0000.00%
View complete list of MEDOVEX CORP shareholders